Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$471.85 USD

471.85
1,418,197

+1.77 (0.38%)

Updated Aug 11, 2025 04:00 PM ET

After-Market: $471.75 -0.10 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (148 out of 244)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Intuitive Surgical (ISRG) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Intuitive Surgical (ISRG) closed at $478.44 in the latest trading session, marking a +1.43% move from the prior day.

Zacks Equity Research

Here's Why You Should Buy Intuitive Surgical (ISRG) Now

by Zacks Equity Research

A solid outlook for 2018 and strength in robotics make Intuitive Surgical (ISRG) a promising investment pick.

Zacks Equity Research

Has Intuitive Surgical (ISRG) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (ISRG) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

The Zacks Analyst Blog Highlights: Intuitive Surgical, HCA Healthcare, Exelon, 3M and Micron

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Intuitive Surgical, HCA Healthcare, Exelon, 3M and Micron

Zacks Equity Research

Intuitive Surgical (ISRG) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Intuitive Surgical (ISRG) closed at $512.25, marking a -0.66% move from the previous day.

Mark Vickery headshot

Top Research Reports for Intuitive Surgical, HCA Healthcare & Exelon

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Exelon (EXC).

Mark Vickery headshot

Top Analyst Reports for Adobe, Morgan Stanley & Enbridge

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Adobe (ADBE), Morgan Stanley (MS) and Enbridge (ENB).

Zacks Equity Research

Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (ISRG) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Intuitive Surgical (ISRG) Stock Moves -0.18%: What You Should Know

by Zacks Equity Research

Intuitive Surgical (ISRG) closed at $520.97 in the latest trading session, marking a -0.18% move from the prior day.

Zacks Equity Research

RTI Surgical Gains From HealthPartners' Nod for SI Surgery

by Zacks Equity Research

RTI Surgical's (RTIX) minimally invasive SImmetry System sees lucrative market prospects for the stock's growth.

Zacks Equity Research

Medtronic's Deal With Nutrino Health to Boost Diabetes Arm

by Zacks Equity Research

Bringing Nutrino under Medtronic's (MDT) Diabetes Group will help the acquirer speed up its growth in the same business.

Zacks Equity Research

Medtronic Gets Health Canada License for Visualase System

by Zacks Equity Research

Medtronic (MDT) adopts initiatives to boost top-line contributions from the Brain Therapies arm.

Zacks Equity Research

Here's Why You Should Buy Intuitive Surgical (ISRG) Now

by Zacks Equity Research

Strength in the surgical platform and an upbeat view for 2018 make Intuitive Surgical (ISRG) a promising pick.

Zacks Equity Research

Insulet's (PODD) Omnipod DASH System Now ISO 27001 Certified

by Zacks Equity Research

Insulet (PODD) is now the only insulin pump company to be awarded with both the ISO 27001 and the DTSec Cybersecurity Standard for Connected Diabetes Device Security certifications.

Zacks Equity Research

Intuitive Surgical (ISRG) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Intuitive Surgical (ISRG) closed at $485.24 in the latest trading session, marking a +0.53% move from the prior day.

Zacks Equity Research

Intuitive Surgical (ISRG) Down 0.7% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (ISRG) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Intuitive Surgical (ISRG) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Intuitive Surgical (ISRG) closed at $498.64 in the latest trading session, marking a -0.95% move from the prior day.

Zacks Equity Research

GNC Holdings (GNC) Q3 Earnings Miss on Soft U.S. Retail

by Zacks Equity Research

GNC Holdings (GNC) discourages with sluggish domestic retail comps. However, it delivers a strong performance in e-commerce business as well as at International segment.

Zacks Equity Research

Looking for a Growth Stock? Why It is Time to Focus on Intuitive Surgical (ISRG)

by Zacks Equity Research

Intuitive Surgical (ISRG) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

Zacks Equity Research

Phibro Animal (PAHC) Q1 Earnings Lag Estimates, Sales Up Y/Y

by Zacks Equity Research

Within Animal Health business of Phirbo Animal (PAHC), reduced selling prices across certain countries partially offset its international volume growth.

Zacks Equity Research

OPKO Health (OPK) Incurs Loss in Q3, Lags Revenue Estimates

by Zacks Equity Research

OPKO Health (OPK) gains from robust demand for its flagship RAYALDEE in Q3; adjusted gross margin remains pressed.

Zacks Equity Research

Haemonetics (HAE) Earnings & Revenues Beat Estimates in Q2

by Zacks Equity Research

Haemonetics' (HAE) year-over-year growth in Q2 is backed by benefits from complexity reduction and investments along with strength in market demand and success from early launches.

Zacks Equity Research

athenahealth (ATHN) Q3 Earnings Beat, Bookings Down Y/Y

by Zacks Equity Research

athenahealth's (ATHN) Business and Services unit sees a strong Q3; 2018 guidance maintained.

Zacks Equity Research

DexCom (DXCM) Beats Q3 Earnings Estimates, Raises '18 View

by Zacks Equity Research

Solid contribution from the Sensor, Transmitter and Receiver segments drives DexCom's (DXCM) Q3 results.